Activation of GPER-1 estradiol receptor downregulates production of testosterone in isolated rat Leydig cells and adult human testis. by Vaucher, L. et al.
Activation of GPER-1 Estradiol Receptor Downregulates
Production of Testosterone in Isolated Rat Leydig Cells
and Adult Human Testis
Laurent Vaucher1,2,3, Michael G. Funaro1, Akanksha Mehta1, Anna Mielnik1, Alexander Bolyakov1,2,
Eric R. Prossnitz4, Peter N. Schlegel1,2, Darius A. Paduch1,2*
1Department of Urology and Reproductive Medicine, Weill Cornell Medical College, New York, New York, United States of America, 2 Population Council, Center for
Biomedical Research, New York, New York, United States of America, 3Department of Urology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland,
4Department of Cell Biology and Physiology, University of New Mexico, Albuquerque, New Mexico, United States of America
Abstract
Purpose: Estradiol (E2) modulates testicular functions including steroidogenesis, but the mechanisms of E2 signaling in
human testis are poorly understood. GPER-1 (GPR30), a G protein-coupled membrane receptor, mediates rapid genomic and
non-genomic response to estrogens. The aim of this study was to evaluate GPER-1 expression in the testis, and its role in
estradiol dependent regulation of steroidogenesis in isolated rat Leydig cells and human testis.
Materials and Methods: Isolated Leydig cells (LC) from adult rats and human testicular tissue were used in this study.
Expression and localization studies of GPER-1 were performed with qRT-PCR, immunofluorescence, immunohistochemistry
and Western Blot. Luteinizing Hormone (LH) -stimulated, isolated LC were incubated with estradiol, G-1 (GPER-1-selective
agonist), and estrogen receptor antagonist ICI 182,780. Testosterone production was measured with radioimmunoassay. LC
viability after incubation with G-1 was measured using 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium, inner salt (MTS) assay.
Results: GPER-1 mRNA is abundantly expressed in rat LC and human testis. Co-localization experiments showed high
expression levels of GPER-1 protein in LC. E2-dependent activation of GPER-1 lowers testosterone production in isolated rats
LCs and in human testis, with statistically and clinically significant drops in testosterone production by 20–30% as compared
to estradiol-naı¨ve LC. The exposure to G-1 does not affect viability of isolated LCs.
Conclusions: Our results indicate that activation of GPER-1 lowers testosterone levels in the rat and human testis. The
expression of GPER-1 in human testis, which lack ERa, makes it an exciting target for developing new agents affecting
testosterone production in men.
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Introduction
Estrogens are necessary for maintaining structural and func-
tional integrity of the male reproductive tract, [1] but little is
known regarding the effects of estradiol on steroidogenesis. The
cellular response to estrogens is mediated through the well-
described nuclear estrogen receptors a and b (ERa, ERb), which
function as ligand-dependent transcription factors; ligand-activat-
ed estrogen receptors bind to estrogen response elements (ERE) in
the genome and modulate gene expression in many tissues,
including those of the male reproductive tract. Animal studies
indicate that estradiol modulates the function of Leydig Cells (LC),
efferent tubules, and epididymis.[2] However, the net effect of
estrogens on testicular function differs between species.[3–5] ERa
has been identified in rodent LC, but not in adult human and non-
human primate LC.[6] Thus, alternative pathways of estrogen-
dependent regulation must exist in human testis.[7,8] Experimen-
tal evidence suggests that a new class of estradiol receptor, GPER-
1, a 7-transmembrane-spanning G protein-coupled receptor
(GPCR), mediates estrogen-dependent rapid signaling in a variety
of estrogen-sensitive cells and tissues.[9,10] Our hypothesis
questioned whether GPER-1 might be important in mediating
estradiol’s effects on steroidogenesis in the human testis, as it has
already been proven that GPER-1 is involved in regulation of
steroidogenesis in fish gonads.[11] Our aim was to reveal the
patterns of GPER-1 expression in human and rat testis, and to
determine if GPER-1 regulates androgen synthesis in isolated rat
LC and human testis. The identification of G-1, the first synthetic
agonist for GPER-1[12] allowed us to differentiate between the
effects of GPER-1 and ER, as G-1 binds with high selectivity to
GPER-1.
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Materials and Methods
Chemicals
17b-estradiol (E2), ICI 182,780 and DMSO were purchased
from Sigma (St. Louis, MO). Triton X, protease inhibitors and
LightCyclerH 480 SYBR Green I Master were purchased from
Roche Molecular Biochemicals (Indianapolis, IN). GPER-1 C-
terminal antibody was kindly provided by Dr. Eric Prossnitz,
GPER-1 N-terminal antibody was purchased from Abcam,
(Cambridge, MA), and Zenon Alexa Fluor Labeling Kit from
Molecular Probes, (Eugene, OR). G-1 was purchased from
Calbiochem (San Diego, CA) and 3H-testosterone from PerkinEl-
mer Life Science (Boston, MA). MTS Titer Cell Proliferation assay
was purchased from Promega Corporation (Madison, WI). Ovine
Luteinizing Hormone was provided by the National Hormone and
Pituitary Program (NIDDK, Bethesda, MD). Except for estradiol,
which was diluted in 30% ethanol:70% Dimethylsulfoxide
(DMSO), all ligands were solubilized in DMSO and kept as
1 mM stock solutions at 220uC.
GPER-1 Expression in Human and Rodent Testis
Immunolocalization of GPER-1. The GPER-1 localization
was performed in sections of adult rat testis and adult human testis
using immunohistochemistry (IHC) and immunofluorescence (IF)
on frozen sections. A total of 10 rats and 12 human samples were
available for experiments. Anti GPER-1 N- and C-terminal
primary antibodies were labeled with Zenon Alexa Fluor 594
Labeling Kit. For co-localization experiments, antibodies against
vimentin (for detection of Sertoli cells) or 3-b-hydroxysteroid
dehydrogenase (3b-HSD) (for LC) were labeled with Zenon Alexa
Fluor 488. The nuclei were counterstained with DAPI (ProLong
Gold antifade, Invitrogen). Specimens without primary antibody
were used as negative controls. Image analysis was performed
using ImagePro for Windows with deconvolution module, after z-
stack files were obtained from each fluorescent channel using a
motorized-stage microscope. For IHC, tissues were fixed in
Bouin’s solution, embedded in paraffin and sectioned. Histo-
Mouse-Maxkit-PAD (Invitrogen 87–9551) was used for detection
of GPER-1 primary antibody.
Western blotting and Immunodetection of GPER-1. To
confirm specificity of the antibody, cells were lysed in 110 ml of
50 mM Tris HCL, 150 mM NaCl, 1 mM EDTA, 1% Triton X-
100, 1% SDS, a mixture of protease inhibitors and sonicated on
Branson S250 Digital Sonifier. Protein concentration was deter-
mined using Invitrogen Quant-it Protein assay kit and Qubit
fluorometer according to the manufacturer’s recommendations.
Equal amounts of protein were resolved on a 10% SDS-
polyacrylamide gel, transferred to Hybond-P PVDF transfer
membrane (Amersham Biosciences), probed overnight at 4uC
with anti-GPER-1 N-terminal antibody (1:200) and anti-GPER-1
C-terminal antibody (1:20,000). Membranes were incubated with
horseradish peroxidase (HRP)-conjugated secondary antibodies
and antigens detected with ECL system (Amersham Biosciences).
Antibodies against b-actin were used for normalization; proteins
extracted from Hec50 cells were used as positive control, and
GPER-1 blocking peptide as negative control. In addition, the
antibody specificity was confirmed in Dr. Prossnitz’s laboratory
using GFP-GPER-1 co-localization (Image 1C).
Quantitative RT-PCR. To evaluate GPER-1 mRNA ex-
pression in testis, quantitative RT-PCR was performed using
GPER-1 primer set (sequence: L- CCTCAACACTCACA-
CACTCTGG, R- GATGTCTGGGCTGGTGCT). Total RNA
(1 mg) was transcribed using reverse transcriptase and hexamer
primers to create cDNA libraries from whole adult rat testes and
isolated adult rat LC. For human studies, total RNA was extracted
Figure 1. Localization studies of GPER-1 in rat testis. A. Immunohistochemistry imaging of adult rat testis. GPER-1 antibody is labeled in red. B.
Immunofluorescence localization analysis of adult rat testis, with GPER-1 labeled in red, and nuclei conterstained with DAPI (blue). C. High resolution
Z-stack imaging with 3D deconvolution obtained from each fluorescent channel using motorized microscope.
doi:10.1371/journal.pone.0092425.g001
Figure 2. Protein/RT-PCR studies of GPER-1 in rat and human
testis. A. Western blot analysis of GPER-1 expression in total protein
extract from adult rat testis, isolated rat Leydig cells, human testis and
Hec50 cell line cells. B. Quantitative RT-PCR in adult rat testis, isolated
rat Leydig cells and human testis. RT: rat testis, RLC: Rat Leydig cells, HT:
Human testis.
doi:10.1371/journal.pone.0092425.g002
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from testis samples obtained from patients with obstructive
azoospermia with normal spermatogenesis. Expression was
normalized to b-actin. LightCyclerH 480 SYBR Green I Master
was used to prepare master mix for qRT-PCR. Standard curves
were generated for the target and housekeeping genes. Melting
curves were analyzed for each reaction. All experiments were
performed using a thermo-cycler (LightCycler 480, Roche) with
the following settings: pre-incubation, 10 min at 95uC, amplifica-
tion: 45 cycles, 95uC610s, 60uC610s, 72uC612s.
GPER-1 Regulation of Androgen Synthesis
Leydig cell preparation. Adult male Sprague-Dawley rats
were purchased from Charles River Laboratories (Wilmington
Mass). A total of 10 animals were sacrificed by CO2 asphyxiation
according to an approved animal protocol (protocol 91200-2R,
Rockefeller University). Purified LC were prepared as previously
described.[13] All experiments were performed using pooled LC
fractions at a time, and each experiment was performed in
triplicate. Leydig cell preparations were 95% 62 pure (3b-HSD
staining). Human testis samples (50 mg) were obtained under IRB
approval (protocol 0709009425) during microsurgical testicular
sperm extraction. Samples from twelve patients were obtained.
The tissue sample was placed in sterile PBS, subsequently
suspended to assure uniform dispersion of cells, and divided into
equal aliquots prior to LH stimulation and adding specific ligands.
Rat and human leydig cell incubation. Testosterone (T)
production by LC was measured after incubation of 0.16106 cells
at 34uC for 3 h in culture media.[13] For each experiment the T
production by LH naı¨ve cells and by cells stimulated with ovine
LH (100 ng/ml) was measured.
Radioimmunoassay (RIA). Testosterone production was
measured in house by RIA in triplicate for each sample as
previously described.[14] The cross reactivity of anti-testosterone
antibody with estrogen was calculated at 0.52% and with ICI 182
780 at 0.16%. Cross reactivity of RIA for G-1 was less than 0.1%.
Dose response curves for ligands. Optimal concentrations
of ligands and antagonists used in subsequent experiments (ICI
182,780 (ICI), 17b Estradiol (E2) and G-1) were determined
experimentally. LC were incubated with increasing concentration
of each component, and the concentration of T in the medium was
measured.
Effect of estradiol, G-1 on testosterone production in
isolated leydig cells. The isolated LC were incubated with
vehicle, E2, G-1, and E2 plus G-1 together with and without LH
stimulation. After three hours, the production of testosterone per
0.16106 cells (rats), or per mg of tissue (human testis) was
measured in each of the vials. Experiments in humans were
performed using 12 testis samples.
Balance between ER and GPER-1 signaling. To clarify the
role of ER signaling plays on testosterone production, the isolated
LC were pre-treated with the pure ER antagonist ICI 182,780
(ICI) before exposing cells to E2 or G-1. ICI 182,780 does not
block the GPER-1 activation.
Secondary signaling through GPER-1. To evaluate if
GPER-1 modulates testosterone production through mechanisms
of GPCRs pathways, the isolated LC were pre-incubated with
pertussis toxin (PTX), which inhibits the inhibitory Gai subunit of
G proteins in LC. 100 ng/ml PTX was added to the medium for
15 minutes prior to adding G-1 and E2 ligands, as described
previously, [15] and the T production was measured subsequently.
Effects of G-1 and DMSO on leydig cell viability. In order
to exclude toxic effects of G-1 or vehicle (DMSO) on LC, the cell
viability was measured after 3 and 12 hours of incubation with and
without increasing concretions of G-1 and DMSO.
MTS assay. LC viability was evaluated using the MTS Cell
Titer Cell Proliferation assay according to the manufacturer’s
instructions.
Statistical analysis. Prism 5 and JMP for Macintosh were
used for statistical analysis (GraphPad Software, Inc, and SAS).
Statistical significance between groups was tested using t-student
and ANOVA tests with post-hoc analysis as appropriate, p values
of,0.05 were considered statistically significant.
Figure 3. Dose response analysis of testosterone production in rat Leydig cells with E2, G-1 and ICI incubation. Final concentration of
10, 50, 100 and 500 nM of each ligand. Non-statistically significant difference between 10, 50 and 100 nM.
doi:10.1371/journal.pone.0092425.g003
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Ethics Statement
All of the work conducted within the experiments was carried
out under IRB approval. Human testis samples were obtained and
subsequent experiments were carried out with the approval of the
Weill Cornell Medical College institutional review board (protocol
0709009425). It was decided by the IRB that neither written nor
verbal consent was necessary for obtaining these human tissue
specimens, as the samples obtained and used in this study were
waste or to-be-discarded samples. Animal studies were carried out
under the approval of the Rockefeller University IRB/IUCAC
protocol 91200-2R. Per protocol, rats were sacrificed with CO2
prior to any further study.
Results
Localization and Expression of GPER-1 in Leydig Cells and
Rats Testis
IHC and IF studies with antibodies against GPER-1 and 3-
bHSD showed abundant expression of GPER-1 within rat and
human LC. IF studies show a strong signal for GPER-1 in rat LC
(Figure 1A). High-resolution Z-stack imaging with 3D deconvolu-
tion indicates that in LC GPER-1 is expressed predominantly
within the cytoplasm (i.e. not the plasma membrane) and most
likely within the endoplasmic reticulum, which is consistent with
data found in breast cancer cell lines (Figure 1B). [16,17].
Western blotting using anti GPER-1 C- and N- terminal
antibodies detected GPER-1 in total protein extracts from isolated
rat LC, human testis and Hec50 endometrial cancer cells
(Figure 2A). Although the predicted molecular weight of the
GPER-1 protein is 40 kDa, GPER-1 can undergo extensive
glycosylation. Experiments with blocking peptide verified that
GPER-1 is expressed by the presence of strong band between 50
and 60 kDa as observed in our experiments.
Quantitative RT-PCR in human and rat showed modest
expression of GPER-1 in whole testis RNA, with a significant
increase (10x) in expression of GPER-1 in isolated LC which is
consistent with the results of IHC showing predominant expression
of GPER-1 in LC (Figure 2B).
Dose Response Effects of G-1, 17b-estradiol and ICI
182,780 on Leydig cell Testosterone Production
Dose response analysis for E2, G-1 and ICI with final
concentrations of 10, 50, 100 and 500 nM of each ligand showed
that there were no statistically significant differences in testoster-
one production at concentration up to 100 nM (Figure 3).
Concentrations of 100 nM for each ligand were used in the
subsequent experiments and correspond to concentrations used by
others.[18].
Inhibition of Testosterone Production by 17b-estradiol
and GPER-1 Agonist G-1
In isolated LC stimulated with LH, a reproducible and
statistically significant decrease in testosterone production was
observed in all experiments after 3 hours of incubation with
estradiol (p,0.05) (Figure 4). To answer the question if GPER-1
signaling is involved in the observed effects of estradiol on
steroidogenesis, G-1, a selective agonist of GPER-1, was used. The
treatment of LH-stimulated LC with G-1 showed a reproducible,
statistically significant drop in testosterone production of 20% (p,
0.05) These results provide supporting evidence that activation of
GPER-1 signaling pathways has an inhibitory effect on testoster-
one production in LC. Addition of G-1 and E2 to LH stimulated
cells demonstrated a inhibitory effect in LH-stimulated cells, with a
30% decrease in testosterone production, which may indicate
synergistic effects of ER and GPER-1 signaling on testosterone
production, or be secondary to an increased concentration of
GPER-1 activating ligands, in our case G-1 and E2 to 200 nM.
Modulation of Testosterone Production by ICI 182,780
In order to exclude modulatory effects of nuclear receptor ERa
and ERb, independently or in crosstalk with GPER-1 on
steroidogenesis, we used the pure estrogen receptor antagonist
ICI 182,780 (Figure 5A). Co-incubation of ICI and E2 in LH-
stimulated cells showed an 8% increase in testosterone production
as compared with E2 LH-stimulated cells, indicating that the
classic nuclear receptor pathways through ERa and ERb play
minimal roles in the effects of estradiol on steroidogenesis. This
Figure 4. Testosterone production in isolated LH stimulated Leydig cells after 3 hours. Co incubation with G-1, E2, G-1 and E2.
doi:10.1371/journal.pone.0092425.g004
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observation was further strengthened by results from co-incuba-
tion of G-1 with ICI, which produced a 12% decrease in
testosterone production as compared to G-1 alone. These data are
consistent with the antagonist effect of ICI on ERa and ERb
receptors, but the agonist effect on GPER-1.[19] As human testis
does not express ERa, incubation with E2, with or without ICI,
did not show any statistically significant difference (data not
shown).
Effects of DMSO on Steroidogenesis
In response to concerns that vehicles like DMSO, which are
used to deliver steroids and steroid receptor ligands, may
themselves modulate testosterone production, [17] the cells were
incubated with DMSO at the same final concentration of DMSO
(0.05–0.1%) as would be used if ligands were added to the
medium. There was no statistically significant difference in
testosterone production in LH-stimulated cells incubated with or
without DMSO.
Effects of Different Concentrations of G-1 on Leydig Cells
Viability
To evaluate if G-1 has negative effect on cell viability and to
answer the question if observed lower production of testosterone is
a result of detrimental effects on LC, the MTS viability assay was
performed using different concentrations of G-1. Data was
analyzed using two-way ANOVA with time and concentrations
as factors. The G-1 has no significant effect on Leydig cell vitality
up to concentration above 100 nM; G-1 at concentration of
1000 nM decreased vitality of LC by 30% after 3 hours of
incubation and 44% after 12 hours (p,0.001). G-1 at concentra-
tion of 100 nM was used in all experiments reported in our study
(Figure 6).
Inhibition of G Inhibitory Subunit of GPCR (Gai)
To further strengthen our hypothesis that estradiol action on
steroidogenesis is conducted through GPCR signaling, we used
pertussis toxin, an inhibitor of the Gai subunit. As LH also acts
through a G protein-coupled receptor, we were able to observe a
statistically significant increase in testosterone production between
LH and LH PTX, which is in agreement with previous
studies.[15,20] Pre-incubated cells with PTX did not show the
characteristic decrease in testosterone production after treatment
with G-1, suggesting that blocking Gai subunit interferes with
GPER-1 signaling (Figure 5B). Moreover, a Gai subunit might be
the a subunit responsible for GPER-1 signal transduction. This
observation has to be further evaluated to differentiate between
effects of PTX on LH and GPER-1 signaling, since both receptors
belong to the GPCR family. E2 added to cells pre-incubated with
PTX led to a statistically significant, (p = 0.03) although very slight,
decrease in testosterone production.
Effect of Estradiol and G-1 on Human Leydig Cell
Testosterone Production
To investigate if GPER-1 signaling is involved in the regulation
of testosterone production in human testis, testis samples were
incubated with G-1 and E2 after LH stimulation. Testosterone
production was first compared separately for each patient to
exclude variation in steroidogenesis between subjects. However, as
the percentage drop of T after G-1 and E2 was similar in all
patients, all results were pooled for statistical analysis using one-
way ANOVA (Figure 7). There was a statistically and clinically
Figure 5. Testosterone production in isolated LH stimulated
Leydig cells after 3 hours. A. Co-incubation with pure estrogen
receptor antagonist ICI 182,780. B. Pre-incubated cells with pertussis
toxin (PTX). 100 ng/ml PTX was added to the medium for 15 minutes
prior to adding G-1 and E2 ligands.
doi:10.1371/journal.pone.0092425.g005
Figure 6. MTS viability assay performed with different
concentrations of G-1, after 3 and 12 hours. Data was analyzed
using two-way ANOVA with time and concentrations as factors.
doi:10.1371/journal.pone.0092425.g006
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significant drop in testosterone production by 26% in the G-1 and
E2 group after 3 hours of incubation. (p,0.05) The fact that the
human testis lacks ER alpha, acting as a ‘‘natural ER alpha
knockout’’, and the lack of statistically significant difference
between the decrease in testosterone production after incubation
with G-1 or E2, provides strong evidence that GPER-1 plays a
significant role in estradiol-dependent modulation of steroidogen-
esis in human testis.
Discussion
Estrogen plays an essential role in the regulation of normal
brain, bone, and reproductive functions in men.[21–23] 17b-
estradiol is known to have inhibitory effects on mature Leydig cell
steroidogenesis in experimental animals[24] and humans;[25,26]
Hardy and colleagues showed an inhibitory effect of estrogen on
cultured rodent LC, clearly indicating that its inhibition of
testosterone secretion is not solely limited to effects at the
hypothalamic-pituitary-gonadal axis.[27] While evidence suggests
additional modes of action, the involvement of estrogen receptors
(ERa and ERb) through direct signaling in the suppression of
steroidogenesis has never been proven in human Leydig cells.
Although ERb is present in the testis, its ubiquitous nature suggests
that it might not be a primary target for estrogen action.[28] In the
testes, immunoexpression of ERa was described in Leydig and in
peritubular myoid cells of adult rodents, [29] but not in primate or
human LC [6].
GPER-1, a novel G protein-coupled estrogen receptor was
shown to be involved in the effects of estrogen in normal and
malignant tissue.[19] The recent availability of a specific GPER-1
agonist with negligible affinity for ERs, [12] already used by others
to investigate GPER-1 activity, [30–32] allowed us to examine the
role of GPER-1 in steroidogenesis. In the present study, we have
established the expression of GPER-1 in LC, and the ability of its
selective agonist, G-1, to induce a decrease in testosterone
production by LC of adult rat and human testis. This decrease
is dose-dependent and occurs within 3 hours, indicating most likely
involvement of nonclassical, nongenomic signaling. We used the
same concentrations of G-1 and E2 in our experiments, and found
a similar decrease in testosterone production when we added G-1
or E2 to LH-stimulated LC. We thus conclude that the decrease in
testosterone production is due to GPER-1 activation. In these
short-term cell cultures, GPER-1 desensitization is unlikely to
explain our results. However, as mentioned by Prossnitz, [19] G-1
may have unknown activity on other receptors or signaling
proteins, and tissue-specific knockdown studies are mandatory and
already planned to confirm the GPER-1 involvement in the
modulation of LC testosterone production. Moreover, the lack of
ERa receptor in human testis provides a unique ‘‘knock-out’’
model to study the effects of GPER-1 signaling, as it eliminates the
classical estrogen signaling pathways. The fact that in human
samples we observed exactly the same decrease in testosterone
production when using estradiol and G-1 indicates that in human
testis GPER-1 is an important pathway in estradiol regulation of
steroidogenesis. It is also worthwhile to investigate the effects of a
GPER-1 antagonist like G15 on steroidogenesis; we have
performed extensive experiments and these results are forthcom-
ing (manuscript in preparation). GPER-1 signaling is most likely
the predominant mechanism of estradiol-driven downregulation of
testosterone production in humans.
Conclusion
GPER-1 signaling is a significant pathway in the regulation of
steroidogenesis by estradiol in rat and human testis. This report
shows that, in human and rats, detrimental effects of estrogen
excess on steroidogenesis act at the testicular level through GPER-
1-dependent signaling.
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